1. Home
  2. DNLI vs MP Comparison

DNLI vs MP Comparison

Compare DNLI & MP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • MP
  • Stock Information
  • Founded
  • DNLI 2013
  • MP 2017
  • Country
  • DNLI United States
  • MP United States
  • Employees
  • DNLI N/A
  • MP N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • MP Metal Mining
  • Sector
  • DNLI Health Care
  • MP Basic Materials
  • Exchange
  • DNLI Nasdaq
  • MP Nasdaq
  • Market Cap
  • DNLI 3.3B
  • MP 3.2B
  • IPO Year
  • DNLI 2017
  • MP N/A
  • Fundamental
  • Price
  • DNLI $21.43
  • MP $18.01
  • Analyst Decision
  • DNLI Strong Buy
  • MP Buy
  • Analyst Count
  • DNLI 11
  • MP 11
  • Target Price
  • DNLI $40.40
  • MP $21.55
  • AVG Volume (30 Days)
  • DNLI 815.8K
  • MP 3.1M
  • Earning Date
  • DNLI 11-06-2024
  • MP 11-07-2024
  • Dividend Yield
  • DNLI N/A
  • MP N/A
  • EPS Growth
  • DNLI N/A
  • MP N/A
  • EPS
  • DNLI N/A
  • MP N/A
  • Revenue
  • DNLI N/A
  • MP $184,074,000.00
  • Revenue This Year
  • DNLI N/A
  • MP N/A
  • Revenue Next Year
  • DNLI $420.35
  • MP $79.04
  • P/E Ratio
  • DNLI N/A
  • MP N/A
  • Revenue Growth
  • DNLI 204.74
  • MP N/A
  • 52 Week Low
  • DNLI $14.56
  • MP $10.02
  • 52 Week High
  • DNLI $33.33
  • MP $24.01
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 31.13
  • MP 41.96
  • Support Level
  • DNLI $22.61
  • MP $19.54
  • Resistance Level
  • DNLI $24.15
  • MP $21.13
  • Average True Range (ATR)
  • DNLI 1.09
  • MP 0.97
  • MACD
  • DNLI -0.15
  • MP -0.34
  • Stochastic Oscillator
  • DNLI 7.59
  • MP 0.92

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About MP MP Materials Corp.

MP Materials Corp is the producer of rare earth materials in the Western Hemisphere. The company owns and operates the Mountain Pass Rare Earth Mine and Processing Facility, the only rare earth mining and processing site of scale in North America.

Share on Social Networks: